Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study

Abstract

Differences in persistence could be, in part, due to unmeasured confounders although all available variables were adjusted in multivariate analyses. Additionally, the claims database lacks some clinical data such as lipid levels, limiting assessments of statin efficacy, and does not include any reasons for discontinuation of therapy.